Leadership Team

Aamir Mahmood

President and CEO

Year of entry:  2024

Born: 1976

Location: USA

Education: BS in Marketing and Management from Oklahoma State University, an MBA from Oklahoma City University, and Executive Education from Harvard Business School

Previous engagements/experience: Aamir has more than twenty years of executive experience in the medical device industry, demonstrating a proven track record in commercial roles within Global cardiovascular device markets. His expertise spans sales, marketing, and strategy functions at organizations such as LivaNova, Boston Scientific, and Merck. Most recently, Aamir served as the General Manager/Vice President, Americas, at MicroPort CRM (MicroPort acquired the organization from LivaNova in 2017), a cardiovascular medical device company with primary focus on cardiac rhythm management, electrophysiology, arrhythmia assessment, and other cardiac devices used for diagnosing, treating, and managing heart rhythm disorders and heart failure. Prior to overseeing the Americas for MicroPort, Aamir rotated through two EXPAT assignments in Europe running Global Sales, followed by Global Marketing and Strategy, including M&A.

Other significant ongoing assignments: Aceco Valves Member, Board of Directors, Biozen Member, Board of Directors, YPO Member

Acarix holdings:
Shares: 5,404,567
Employee Options: 50,000,000

Christian Lindholm

Chief Financial Officer

Year of entry: 2016

Born: 1964

Location: Sweden

Education: Business Administration at the University of Växjö and Kristianstad University.

Previous engagements/experience: For the past 17 years, he has held positions as CFO in both private and listed companies. Prior to joining Acarix, Christian Lindholm was CFO of Doro AB and TFS International AB.

Other significant ongoing assignments: Board Member of Lindholm Finance AB.

Acarix holdings:
Shares: 79,328
Employee Options: 4,000,000

Dwyndl Nelms

Head of QA, RA and Production

Education: BS General Studies from Arkansas State University, MS in Divinity Studies from Mid-America Baptist Theological Seminary and Certified Lead Auditor for ISO 134485:2016 and ISO 9001:2015.

Previous engagement/experience: Dwyndl joins us from MicroPort CRM, a cardiovascular medical device company with primary focus on cardiac rhythm management, where he served as QA Manager for the Americas and Asia-Pacific regions. With over 20 years of experience in the medical device industry, Dwyndl has progressed from the manufacturing floor to becoming a respected leader in quality management.  He brings a wealth of expertise in quality systems, regulatory compliance, and advanced problem-solving techniques. A proven track record of helping companies achieve ISO certification, as well as successfully navigating inspections by the FDA and other regulatory bodies, underscores his value to our organization. Known for his innovative approach, Dwyndl excels at creating streamlined yet comprehensive procedures that drive both efficiency and compliance.

Carma Connely

Head of Market Access & Customer Excellence

Year of entry: 2022

Born: 1975

Location: USA

Education: BS in Chemistry from Butler University, IN and MS in Biochemistry from University of Denver, CO.

Previous engagements/experience: Carma has over 20 years of experience in the medical device field with a focus on neurosurgery and cardiology. She has experience in sales, product management, quality, regulatory, operations, clinical education, and finance. Carma previously held roles as Vice President of Operations at Coala Life, Product Management at Raumedic and launched multiple European companies into the US market.

Acarix holdings:
Shares: 408,520
Employee Options: 658,520

Jennifer Matson

Head of Medical Affairs

Year of entry: 2022

Born: 1977

Location: USA

Education: BSc in Biomedical Engineering from Boston University, MA and Master of Public Health from Johns Hopkins Bloomberg School of Public Health, MD.

Previous engagements/experience: Jennifer has more than 20 years of experience in research and development, clinical, and product innovation in the medical device industry (FDA class II and III, including HDE) internationally for Biotronik, Bayer and start-ups. Her career also includes experience leading program evaluation for healthcare reform initiatives as part of a Medicare and Medicaid Innovation grant.

Acarix holdings:
Employee Options: 658,520

Jeff Thomas

Head of US Sales 

Year of entry: 2024

Born: 1969

Location: USA

Education: Jeff holds a Bachelor of Science in Engineering from the Colorado School of Mines in Golden, Colorado.

Previous Engagements/Experience: Jeff has more than 20 years of experience in sales and sales leadership within the medical device industry. He has been successful in both early-stage start-ups and established market leaders, with a focus on the cardiovascular device sector. Jeff has gained expertise in sales, sales leadership, and strategic functions through his roles at organizations such as Ethicon Endo-Surgery, Computer Motion, Guidant Corp (now part of Boston Scientific), St. Jude Medical (now part of Abbott), and Biotronik, Inc. Most recently, Jeff was the Executive Vice President of Sales & Business Development for a Texas-based start-up focused on sleep, health, and wellness. In this position, he played a key role in driving business growth and expanding market presence, leveraging his deep industry knowledge and strategic acumen.

Acarix holdings:
Employee Options: 2,000,000

George Chrysant

MD as Chief Medical Advisor

Year of entry: 2024

Location: USA

Education: Medical School (University of Oklahoma)

Residency: University of Alabama-Birmingham Cardiology/Interventional
Cardiology: Washington University School of Medicine Cardiac CT Fellowship: Harbor-UCLA

Previous engagements/experience: Chief Medical Officer for INTEGRIS Cardiovascular Physicians. Board certified in Cardiovascular Diseases, Interventional Cardiology and Cardiac CT. Special interest in complex coronary imaging and physiology as well as cardiac CT and FFRct. Was local PI in both PROMISE and PRECISE trials.

For Investors

Corporate Governance

Financial Reports

Investor Presentations